Varenicline Tablet, Film Coated
Product Images NDC 72162-2218

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 72162-2218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A bar chart titled 'Continuous Abstinence, Weeks 9 through 12' comparing the percentage of continuous abstinence across five studies for different treatments. The chart shows percentage values on the y-axis (0% to 60%) and treatment groups on the x-axis, including Varenicline 0.5 mg, Varenicline 1.0 mg BID, placebo, Varenicline Flexible, Bupropion SR 150 mg BID, with varying responses across studies 2 to 5. Some bars include error bars indicating variability in the data.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A bar chart titled 'Figure 2: Continuous Abstinence, Weeks 9 through 52' comparing the percentage of continuous abstinence across different studies for treatments including Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and placebo. The chart displays mean values with error bars indicating variability for each group.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph comparing the percentage of continuous abstinent subjects over time between Varenicline 1.0 mg twice daily and placebo groups. The x-axis represents nontreatment follow-up in weeks, and the y-axis shows the percentage of continuous abstinent subjects. The graph shows a general decline in abstinence percentage over time for both groups, with Varenicline maintaining higher abstinence rates than placebo throughout the follow-up period.*
FDA Label Image

Label (Lbl721622218)

Label (Lbl721622218)
The label for Varenicline Tablets 0.5 mg, film-coated oral tablets, relabeled by Bryant Ranch Prepack and manufactured by Apotex Inc. The package contains 56 tablets. The label includes dosage strength, storage instructions, dispensing guidelines, and a barcode with NDC 72162-2218-2.*
FDA Label Image

Structure-1 (Structure 1)

Structure-1 (Structure 1)
Chemical structure of varenicline, the active ingredient. The image shows the molecular formula with distinct ring structures, hydroxyl groups, carboxyl groups, and amino groups as part of the chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.